Literature DB >> 30589534

The RTK Interactome: Overview and Perspective on RTK Heterointeractions.

Michael D Paul1, Kalina Hristova1.   

Abstract

Receptor tyrosine kinases (RTKs) play important roles in cell growth, motility, differentiation, and survival. These single-pass membrane proteins are grouped into subfamilies based on the similarity of their extracellular domains. They are generally thought to be activated by ligand binding, which promotes homodimerization and then autophosphorylation in trans. However, RTK interactions are more complicated, as RTKs can interact in the absence of ligand and heterodimerize within and across subfamilies. Here, we review the known cross-subfamily RTK heterointeractions and their possible biological implications, as well as the methodologies which have been used to study them. Moreover, we demonstrate how thermodynamic models can be used to study RTKs and to explain many of the complicated biological effects which have been described in the literature. Finally, we discuss the concept of the RTK interactome: a putative, extensive network of interactions between the RTKs. This RTK interactome can produce unique signaling outputs; can amplify, inhibit, and modify signaling; and can allow for signaling backups. The existence of the RTK interactome could provide an explanation for the irreproducibility of experimental data from different studies and for the failure of some RTK inhibitors to produce the desired therapeutic effects. We argue that a deeper knowledge of RTK interactome thermodynamics can lead to a better understanding of fundamental RTK signaling processes in health and disease. We further argue that there is a need for quantitative, thermodynamic studies that probe the strengths of the interactions between RTKs and their ligands and between different RTKs.

Entities:  

Year:  2018        PMID: 30589534      PMCID: PMC6918702          DOI: 10.1021/acs.chemrev.8b00467

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   60.622


  472 in total

Review 1.  Recent advances in charting protein-protein interaction: mass spectrometry-based approaches.

Authors:  Anne-Claude Gavin; Kenji Maeda; Sebastian Kühner
Journal:  Curr Opin Biotechnol       Date:  2010-10-09       Impact factor: 9.740

2.  Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis.

Authors:  N W Gale; S J Holland; D M Valenzuela; A Flenniken; L Pan; T E Ryan; M Henkemeyer; K Strebhardt; H Hirai; D G Wilkinson; T Pawson; S Davis; G D Yancopoulos
Journal:  Neuron       Date:  1996-07       Impact factor: 17.173

3.  Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation.

Authors:  F Rossi; C A Charlton; H M Blau
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

4.  Fully quantified spectral imaging reveals in vivo membrane protein interactions.

Authors:  Christopher King; Michael Stoneman; Valerica Raicu; Kalina Hristova
Journal:  Integr Biol (Camb)       Date:  2016-01-20       Impact factor: 2.192

5.  EphB6 promotes anoikis by modulating EphA2 signaling.

Authors:  Mai Akada; Kohei Harada; Manabu Negishi; Hironori Katoh
Journal:  Cell Signal       Date:  2014-09-17       Impact factor: 4.315

Review 6.  The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer.

Authors:  Ying Wang; Kwaku Appiah-Kubi; Min Wu; Xiaoyuan Yao; Hai Qian; Yan Wu; Yongchang Chen
Journal:  Growth Factors       Date:  2016-05-12       Impact factor: 2.511

7.  Phosphatidylinositol-4,5-bisphosphate regulates epidermal growth factor receptor activation.

Authors:  Ioannis E Michailidis; Radda Rusinova; Anastasios Georgakopoulos; Yibang Chen; Ravi Iyengar; Nikolaos K Robakis; Diomedes E Logothetis; Lia Baki
Journal:  Pflugers Arch       Date:  2010-11-24       Impact factor: 3.657

Review 8.  The Met tyrosine kinase receptor in development and cancer.

Authors:  Alessandra Gentile; Livio Trusolino; Paolo M Comoglio
Journal:  Cancer Metastasis Rev       Date:  2008-03       Impact factor: 9.264

9.  VEGFR-2 conformational switch in response to ligand binding.

Authors:  Sarvenaz Sarabipour; Kurt Ballmer-Hofer; Kalina Hristova
Journal:  Elife       Date:  2016-04-07       Impact factor: 8.140

10.  Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.

Authors:  Won-Sik Shin; Yuri Hong; Hae Won Lee; Seung-Taek Lee
Journal:  Oncotarget       Date:  2016-11-08
View more
  17 in total

Review 1.  Discoidin domain receptors: Micro insights into macro assemblies.

Authors:  Gunjan Agarwal; Adam W Smith; Blain Jones
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-06-21       Impact factor: 4.739

2.  Revisiting a controversy: The effect of EGF on EGFR dimer stability.

Authors:  Deo R Singh; Christopher King; Matt Salotto; Kalina Hristova
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-07-08       Impact factor: 3.747

Review 3.  Pondering the mechanism of receptor tyrosine kinase activation: The case for ligand-specific dimer microstate ensembles.

Authors:  Kelly Karl; Kalina Hristova
Journal:  Curr Opin Struct Biol       Date:  2021-08-13       Impact factor: 6.809

Review 4.  Unravelling cell migration: defining movement from the cell surface.

Authors:  Francisco Merino-Casallo; Maria Jose Gomez-Benito; Silvia Hervas-Raluy; Jose Manuel Garcia-Aznar
Journal:  Cell Adh Migr       Date:  2022-12       Impact factor: 3.255

5.  Quantifying the strength of heterointeractions among receptor tyrosine kinases from different subfamilies: Implications for cell signaling.

Authors:  Michael D Paul; Hana N Grubb; Kalina Hristova
Journal:  J Biol Chem       Date:  2020-05-27       Impact factor: 5.157

Review 6.  The transition model of RTK activation: A quantitative framework for understanding RTK signaling and RTK modulator activity.

Authors:  Michael D Paul; Kalina Hristova
Journal:  Cytokine Growth Factor Rev       Date:  2019-11-01       Impact factor: 7.638

7.  Interactions between Ligand-Bound EGFR and VEGFR2.

Authors:  Michael D Paul; Kalina Hristova
Journal:  J Mol Biol       Date:  2021-04-20       Impact factor: 6.151

8.  EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastoma.

Authors:  Alan T Yeo; Hyun Jung Jun; Vicky A Appleman; Piyan Zhang; Hemant Varma; Jann N Sarkaria; Al Charest
Journal:  Oncogene       Date:  2021-03-11       Impact factor: 8.756

Review 9.  Ligand bias in receptor tyrosine kinase signaling.

Authors:  Kelly Karl; Michael D Paul; Elena B Pasquale; Kalina Hristova
Journal:  J Biol Chem       Date:  2020-10-29       Impact factor: 5.157

10.  Bioinformatic Analysis of Hepatocellular Carcinoma Cell Lines to the Efficacy of Nimotuzumab.

Authors:  Yu Wang; Meng Zhang; Yixin Gong; Qiyan Wu; Lijun Zhang; Shunchang Jiao
Journal:  Int J Gen Med       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.